Dalian Central Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials
• Gout1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Xinqiao Hospital of Chongqing2 trials
• Tasly Pharmaceutical Group Co., Ltd1 trial

Running trials

• Not yet recruiting

  A Multicenter, Open-label, Randomized, Non-inferiority Clinical Trial With Blinded Endpoint Assessment of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke

  NCT07842185· Phase 2/3· Xinqiao Hospital of Chongqing· Source

  Contact: Guoyong Zeng, doctor

• Recruiting

  A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)

  NCT05230914· Xinqiao Hospital of Chongqing· Source

  Contact: Zhongjun Chen, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke2 recruiting

Closed trials

• Completed

  A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

  NCT06068478· Phase 3· Tasly Pharmaceutical Group Co., Ltd· Source